Fox Run Management L.L.C. Takes $788,000 Position in Globe Life Inc. $GL

Fox Run Management L.L.C. purchased a new stake in Globe Life Inc. (NYSE:GL) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 5,509 shares of the company’s stock, valued at approximately $788,000.

A number of other large investors also recently bought and sold shares of GL. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Globe Life by 6.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,391 shares of the company’s stock valued at $1,237,000 after buying an additional 607 shares in the last quarter. NewEdge Advisors LLC grew its stake in Globe Life by 368.1% in the 1st quarter. NewEdge Advisors LLC now owns 6,806 shares of the company’s stock valued at $897,000 after acquiring an additional 5,352 shares during the period. Goldman Sachs Group Inc. increased its holdings in Globe Life by 11.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 563,021 shares of the company’s stock worth $74,161,000 after acquiring an additional 58,163 shares in the last quarter. Empowered Funds LLC acquired a new position in Globe Life during the first quarter worth $428,000. Finally, Focus Partners Wealth lifted its holdings in Globe Life by 8.3% during the first quarter. Focus Partners Wealth now owns 8,559 shares of the company’s stock valued at $1,127,000 after purchasing an additional 656 shares in the last quarter. Institutional investors and hedge funds own 81.61% of the company’s stock.

Analysts Set New Price Targets

GL has been the subject of several research analyst reports. Wells Fargo & Company upped their price target on shares of Globe Life from $170.00 to $171.00 and gave the stock an “overweight” rating in a research report on Wednesday. Piper Sandler reiterated an “overweight” rating and set a $167.00 price target on shares of Globe Life in a research report on Friday, November 21st. Weiss Ratings raised Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday, February 13th. Truist Financial lifted their target price on shares of Globe Life from $158.00 to $180.00 and gave the stock a “buy” rating in a research note on Friday, February 6th. Finally, TD Cowen reaffirmed a “buy” rating on shares of Globe Life in a report on Thursday, December 11th. Eight research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $171.33.

Globe Life Stock Performance

Shares of Globe Life stock opened at $146.06 on Friday. The company has a debt-to-equity ratio of 0.41, a current ratio of 0.07 and a quick ratio of 0.07. The stock has a market capitalization of $11.63 billion, a price-to-earnings ratio of 10.37 and a beta of 0.47. The business has a 50-day moving average of $141.76 and a 200 day moving average of $138.69. Globe Life Inc. has a 12 month low of $109.38 and a 12 month high of $152.71.

Globe Life (NYSE:GL) last released its earnings results on Wednesday, February 4th. The company reported $3.39 EPS for the quarter, missing the consensus estimate of $3.44 by ($0.05). Globe Life had a return on equity of 21.75% and a net margin of 19.37%.The company had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.53 billion. During the same period in the previous year, the firm earned $3.14 earnings per share. The company’s revenue for the quarter was up 3.6% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. As a group, sell-side analysts forecast that Globe Life Inc. will post 13.87 earnings per share for the current year.

Globe Life Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 1st. Shareholders of record on Friday, April 3rd will be given a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 0.9%. This is a positive change from Globe Life’s previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Thursday, April 2nd. Globe Life’s dividend payout ratio is presently 7.67%.

Insider Buying and Selling at Globe Life

In other news, Director Mark A. Blinn sold 1,750 shares of the company’s stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $147.91, for a total value of $258,842.50. Following the completion of the sale, the director directly owned 3,372 shares of the company’s stock, valued at approximately $498,752.52. This represents a 34.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Michael Clay Majors sold 30,000 shares of the stock in a transaction on Friday, February 6th. The stock was sold at an average price of $146.89, for a total value of $4,406,700.00. Following the sale, the executive vice president directly owned 47,066 shares of the company’s stock, valued at approximately $6,913,524.74. This represents a 38.93% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 63,629 shares of company stock worth $9,223,785 in the last 90 days. Company insiders own 1.51% of the company’s stock.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.